Number of Participants With Adverse Events for Long Term Safety and Tolerability Baseline through 4 years [clinicaltrials_resource:ba7b191aef2c85bbb35bfbe68545886a]
Details on the actual adverse events are presented in the Reported Adverse Events Section.
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]
Number of Participants With Adverse Events for Long Term Safety and Tolerability Baseline through 4 years [clinicaltrials_resource:ba7b191aef2c85bbb35bfbe68545886a]
Details on the actual adverse events are presented in the Reported Adverse Events Section.
Bio2RDF identifier
ba7b191aef2c85bbb35bfbe68545886a
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:ba7b191aef2c85bbb35bfbe68545886a
measure [clinicaltrials_vocabulary:measure]
Number of Participants With Adverse Events for Long Term Safety and Tolerability
time frame [clinicaltrials_vocabulary:time-frame]
Baseline through 4 years
description
Details on the actual adverse ...... ported Adverse Events Section.
identifier
clinicaltrials_resource:ba7b191aef2c85bbb35bfbe68545886a
title
Number of Participants With Ad ...... ility Baseline through 4 years
@en
type
label
Number of Participants With Ad ...... b191aef2c85bbb35bfbe68545886a]
@en